
Category Neuropad screening test


Use of Neuropad® as a screening test shown to be highly cost-effective

Neuropad® – a simple, effective indicator for early neuropathy

Cost effectiveness of Neuropad® screening based on NHS data

Comparing Neuropad® to the 10g monofilament and biothesiometer

Advantages of early diagnosis of diabetic neuropathy

NICE publishes its Neuropad® Adoption Scoping Report

Diabetic peripheral neuropathy is a major complication in type 1 and 2 diabetes

NICE to develop Neuropad® guidance

Neuropad® a ‘great innovation’ says NHS

Neuropad® detects hidden autonomic nerve damage in Colombian patients with type 2 diabetes

